231 related articles for article (PubMed ID: 29549194)
1. Emilia-Romagna Study on Pregnancy and Exposure to Antiepileptic drugs (ESPEA): a population-based study on prescription patterns, pregnancy outcomes and fetal health.
Mostacci B; Bisulli F; Poluzzi E; Cocchi G; Piccinni C; Curti A; Simonazzi G; Astolfi G; Rizzo N; Zenesini C; D'Alessandro R; Tinuper P;
J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):983-988. PubMed ID: 29549194
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
[TBL] [Abstract][Full Text] [Related]
3. Obstetric outcomes and effects on babies born to women treated for epilepsy during pregnancy in a resource limited setting: a comparative cohort study.
Galappatthy P; Liyanage CK; Lucas MN; Jayasekara DTLM; Abhayaratna SA; Weeraratne C; De Abrew K; Gunaratne PS; Gamage R; Wijeyaratne CN
BMC Pregnancy Childbirth; 2018 Jun; 18(1):230. PubMed ID: 29898689
[TBL] [Abstract][Full Text] [Related]
4. The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months.
Vajda FJ; O'Brien TJ; Hitchcock A; Graham J; Lander C
J Clin Neurosci; 2003 Sep; 10(5):543-9. PubMed ID: 12948456
[TBL] [Abstract][Full Text] [Related]
5. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
[TBL] [Abstract][Full Text] [Related]
6. Development of an algorithm to identify pregnancy episodes and related outcomes in health care claims databases: An application to antiepileptic drug use in 4.9 million pregnant women in France.
Blotière PO; Weill A; Dalichampt M; Billionnet C; Mezzarobba M; Raguideau F; Dray-Spira R; Zureik M; Coste J; Alla F
Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):763-770. PubMed ID: 29763992
[TBL] [Abstract][Full Text] [Related]
7. Fetal growth and premature delivery in pregnant women on antiepileptic drugs.
Hernández-Díaz S; McElrath TF; Pennell PB; Hauser WA; Yerby M; Holmes LB;
Ann Neurol; 2017 Sep; 82(3):457-465. PubMed ID: 28856694
[TBL] [Abstract][Full Text] [Related]
8. Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study.
Kilic D; Pedersen H; Kjaersgaard MI; Parner ET; Vestergaard M; Sørensen MJ; Olsen J; Bech BH; Christensen J; Pedersen LH
Epilepsia; 2014 Nov; 55(11):1714-21. PubMed ID: 25231599
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP.
Tomson T; Battino D; Bonizzoni E; Craig JJ; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
Neurology; 2015 Aug; 85(7):580-8. PubMed ID: 26187231
[TBL] [Abstract][Full Text] [Related]
10. Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy.
Razaz N; Tomson T; Wikström AK; Cnattingius S
JAMA Neurol; 2017 Aug; 74(8):983-991. PubMed ID: 28672292
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drugs, foetal malformations and spontaneous abortions.
Vajda FJ; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
Acta Neurol Scand; 2017 Mar; 135(3):360-365. PubMed ID: 27573510
[TBL] [Abstract][Full Text] [Related]
12. Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland.
Artama M; Gissler M; Malm H; Ritvanen A;
Drug Saf; 2013 May; 36(5):359-69. PubMed ID: 23615755
[TBL] [Abstract][Full Text] [Related]
13. Antiepileptic drug use among women from the Taiwanese Registry of Epilepsy and Pregnancy: Obstetric complications and fetal malformation outcomes.
Yeh CC; Lussier EC; Sun YT; Lan TY; Yu HY; Chang TY
PLoS One; 2017; 12(12):e0189497. PubMed ID: 29253023
[TBL] [Abstract][Full Text] [Related]
14. Do Anti-Epileptic Drug modifications after first trimester of pregnancy influence fetal malformation or cognitive outcome?
Asranna A; Jose M; Philip RM; Sarma PS; Thomas SV
Epilepsy Res; 2018 Oct; 146():121-125. PubMed ID: 30098567
[TBL] [Abstract][Full Text] [Related]
15. Termination of pregnancy in women with epilepsy - A retrospective single center study.
Goldstein L; Shihman B; Amiel N; Benninger F
Epilepsy Behav; 2018 Oct; 87():89-91. PubMed ID: 30131224
[TBL] [Abstract][Full Text] [Related]
16. Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study.
Wide K; Winbladh B; Källén B
Acta Paediatr; 2004 Feb; 93(2):174-6. PubMed ID: 15046269
[TBL] [Abstract][Full Text] [Related]
17. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study.
Tanganelli P; Regesta G
Neurology; 1992 Apr; 42(4 Suppl 5):89-93. PubMed ID: 1574184
[TBL] [Abstract][Full Text] [Related]
18. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India.
Thomas SV; Jose M; Divakaran S; Sankara Sarma P
Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
[TBL] [Abstract][Full Text] [Related]
20. Congenital malformations in infants exposed to antiepileptic medications in utero at Boston Medical Center from 2003 to 2010.
Deck GM; Nadkarni N; Montouris GD; Lovett A
Epilepsy Behav; 2015 Oct; 51():166-9. PubMed ID: 26283306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
